Skip to main content
. 2022 Jul 3;2(3):148–154. doi: 10.1016/j.jncc.2022.06.003

Table 2.

Distribution of the number of 15 HPV genotypesa detected by cervical swab and biopsy specimens using LiPA-25 and other 7 assays.

Methods No. of samples 0 type (%) All positive (%) Single type (%) Multiple types (%)
Pb
≥ 2 types 2 types (%) 3 types (%) ≥ 4 types (%)
Swab
 LiPA-25 1,726 725 (42.0) 1,001 (58.0) 664 (38.5) 337 (19.5) 269 (15.6) 55 (3.2) 13 (0.7)
 Bohui-24 1,725 847 (49.1) 878 (50.9) 571 (33.1) 307 (17.8) 224 (13.0) 70 (4.1) 13 (0.7) 0.587
 Yaneng-23 1,719 790 (46.0) 929 (54.0) 631 (36.7) 298 (17.3) 228 (13.2) 60 (3.5) 10 (0.6) 0.490
 Tellgen-27 1,697 846 (49.9) 851 (50.1) 557 (32.8) 294 (17.3) 222 (13.1) 56 (3.3) 16 (0.9) 0.706
 Hybribio-16 1,710 799 (46.7) 911 (53.3) 605 (35.4) 306 (17.9) 235 (13.8) 60 (3.5) 11 (0.6) 1.000
 Hybribio-23 1,715 748 (43.6) 967 (56.4) 615 (35.9) 352 (20.5) 254 (14.8) 77 (4.5) 21 (1.2) 0.221
 Bioperfectus-21 1,726 710 (41.1) 1,016 (58.9) 596 (34.6) 420 (24.3) 287 (16.6) 107 (6.2) 26 (1.5) < 0.001
 Sansure-26 1,726 640 (37.1) 1,086 (62.9) 620 (35.9) 466 (27.0) 298 (17.3) 121 (7.0) 47 (2.7) < 0.001
Biopsy
 LiPA-25 56 4 (7.1) 52 (92.9) 52 (92.9) 0 (0) 0 (0) 0 0
 Bohui-24 56 6 (10.7) 50 (89.3) 50 (89.3) 0 (0) 0 (0) 0 0 -
 Yaneng-23 56 4 (7.1) 52 (92.9) 49 (87.5) 3 (5.4) 3 (5.4) 0 0 0.118
 Tellgen-27 56 3 (5.4) 53 (94.6) 51 (91.0) 2 (3.6) 2 (3.6) 0 0 0.495
 Hybribio-16 56 3 (5.4) 53 (94.6) 49 (87.5) 4 (7.1) 4 (7.1) 0 0 0.118
 Hybribio-23 56 3 (5.4) 53 (94.6) 47 (83.9) 6 (10.7) 5 (8.9) 1 (1.8) 0 0.027
 Bioperfectus-21 56 4 (7.1) 52 (92.9) 49 (87.5) 3 (5.4) 3 (5.4) 0 0 0.118
 Sansure-26 56 2 (3.6) 54 (96.4) 45 (80.3) 9 (16.1) 9 (16.1) 0 0 0.003
a

HPV types 6, 11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 66.

b

Chi-square test or Fisher's exact test, the difference between LiPA-25 and other 7 assays for the detection of single versus multiple genotypes (≥ 2 types).

Abbreviation: HPV, human papillomavirus.